ShiraTronics chronic migraine treatment demonstrates long-term efficacy
With its pilot study completed, ShiraTronics is now conducting a pivotal trial of its chronic migraine therapy system, with a readout set for 2026.
15 September 2025
With its pilot study completed, ShiraTronics is now conducting a pivotal trial of its chronic migraine therapy system, with a readout set for 2026.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.